We are live on ! Find out more
SNY icon

Sanofi
SNY

587 hedge funds and large institutions have $9.61B invested in Sanofi in 2022 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 192 increasing their positions, 209 reducing their positions, and 125 closing their positions.

New
Increased
Maintained
Reduced
Closed

212% more call options, than puts

Call options by funds: $234M | Put options by funds: $74.8M

8% more funds holding in top 10

Funds holding in top 10: 13 → 14 (+1)

0.3% less ownership

Funds ownership: 20.42% → 20.12% (-0.3%)

8% less repeat investments, than reductions

Existing positions increased: 192 | Existing positions reduced: 209

10% less funds holding

Funds holding: 655 → 587 (-68)

26% less capital invested

Capital invested by funds: $12.9B → $9.61B (-$3.33B)

48% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 125

Holders
587
Holders Change
-68
Holders Change %
-10.38%
% of All Funds
10.11%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.24%
New
65
Increased
192
Reduced
209
Closed
125
Calls
$234M
Puts
$74.8M
Net Calls
+$159M
Net Calls Change
+$77.6M

Top Buyers

1
Boston Partners
Boston Partners
Massachusetts
+$259M
2
CCM
Camber Capital Management
Massachusetts
+$156M
3
JP Morgan Chase
JP Morgan Chase
New York
+$114M
4
Millennium Management
Millennium Management
New York
+$80.1M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$62.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$220M
2
Fisher Asset Management
Fisher Asset Management
Washington
-$162M
3
Bank of America
Bank of America
North Carolina
-$115M
4
BlackRock
BlackRock
New York
-$114M
5
Lazard Asset Management
Lazard Asset Management
New York
-$78.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
MA
501
MCF Advisors
Kentucky
$12K – – –
BWP
502
Baldwin Wealth Partners
Massachusetts
$11K – – –
KLWA
503
Kelly Lawrence W & Associates
California
$11K – – –
KTC
504
Kistler-Tiffany Companies
Pennsylvania
$11K – – –
TWM
505
Tradition Wealth Management
Minnesota
$11K – – –
ZIG
506
Zullo Investment Group
Pennsylvania
$11K +$13.4K +300 New
FMII
507
Farmers & Merchants Investments Inc
Nebraska
$10K -$23.1K -518 -66%
HWA
508
Heritage Wealth Advisors
Virginia
$9.51K – – –
CT
509
Cambridge Trust
Massachusetts
$9K -$16K -360 -59%
MCM
510
Manchester Capital Management
Vermont
$9K -$6.37K -143 -38%
SBL
511
Sargent Bickham Lagudis
Colorado
$9K – – –
CB
512
Community Bank
New York
$9K +$10.3K +231 New
PFSC
513
Peoples Financial Services Corp
Pennsylvania
$8K -$13.4K -300 -60%
AA
514
AlphaMark Advisors
Kentucky
$8K – – –
BCM
515
Blume Capital Management
California
$8K – – –
EIM
516
Essex Investment Management
Massachusetts
$8K – – –
HC
517
Hoese & Co
Minnesota
$8K – – –
IBOK
518
Independence Bank of Kentucky
Kentucky
$8K – – –
JIR
519
James Investment Research
Ohio
$8K – – –
SN
520
Sittner & Nelson
Oregon
$8K – – –
SSG
521
Summit Securities Group
New York
$8K – – –
CFFP
522
Center for Financial Planning
Michigan
$8K +$5.12K +115 +115%
BCMLT
523
Beacon Capital Management LLC (Tennessee)
Tennessee
$7K – – –
GWSG
524
GPS Wealth Strategies Group
Colorado
$7K – – –
MRCM
525
M&R Capital Management
New Jersey
$7K +$4.46K +100 +100%
19 20
21
22 23

SNY Hedge Fund Activity: Q3 2022 in Review

587 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2022, worth a combined $9.61B — down 26% from $12.9B a quarter earlier.

Sellers outnumbered buyers: 125 funds closed out of SNY and 65 opened new positions — a net loss of 60 holders — while 209 trimmed existing stakes and 192 added.

The largest buyer was Boston Partners, adding an estimated $259M. The largest seller was T. Rowe Price Associates, cutting an estimated $220M.

  • 587 institutional investors held Sanofi (SNY) as of Q3 2022, down from 655 in Q2 2022.
  • Funds reported $9.61B of Sanofi stock for Q3 2022, down 26% quarter-over-quarter.
  • 65 funds opened new Sanofi positions in Q3 2022 and 125 closed out, a net change of -60 holders.
  • The largest Sanofi buyer in Q3 2022 was Boston Partners, an estimated $259M added.
  • The largest Sanofi seller in Q3 2022 was T. Rowe Price Associates, an estimated $220M sold.

Based on aggregated 13F filings for Q3 2022.